144 related articles for article (PubMed ID: 15168965)
1. Ethinyl estradiol/drospirenone (Yasmin): a newer oral contraceptive.
Somma MA
Am Fam Physician; 2004 May; 69(10):2425-6. PubMed ID: 15168965
[No Abstract] [Full Text] [Related]
2. Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
Dickerson V
J Reprod Med; 2002 Nov; 47(11 Suppl):985-93. PubMed ID: 12497673
[TBL] [Abstract][Full Text] [Related]
3. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen.
Parsey KS; Pong A
Contraception; 2000 Feb; 61(2):105-11. PubMed ID: 10802275
[TBL] [Abstract][Full Text] [Related]
4. Drospirenone: a novel progestin.
Rapkin AJ; Winer SA
Expert Opin Pharmacother; 2007 May; 8(7):989-99. PubMed ID: 17472544
[TBL] [Abstract][Full Text] [Related]
5. Evolution of progestins. Focus on the novel progestin drospirenone.
Thorneycroft IH
J Reprod Med; 2002 Nov; 47(11 Suppl):975-80. PubMed ID: 12497671
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a new oral contraceptive containing drospirenone.
Shulman LP
J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
[TBL] [Abstract][Full Text] [Related]
7. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
Batukan C; Muderris II
Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
[TBL] [Abstract][Full Text] [Related]
9. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
Oelkers WH
Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
[TBL] [Abstract][Full Text] [Related]
10. Added benefits of drospirenone for compliance.
Foidart JM
Climacteric; 2005 Oct; 8 Suppl 3():28-34. PubMed ID: 16203653
[TBL] [Abstract][Full Text] [Related]
11. [The latest progestagens].
Belaïsch J; Eliakim V
Contracept Fertil Sex; 1993 Apr; 21(4):287-93. PubMed ID: 7951628
[TBL] [Abstract][Full Text] [Related]
12. Use of an oral contraceptive containing drospirenone in an extended regimen.
Sillem M; Schneidereit R; Heithecker R; Mueck AO
Eur J Contracept Reprod Health Care; 2003 Sep; 8(3):162-9. PubMed ID: 14667328
[TBL] [Abstract][Full Text] [Related]
13. A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido.
Oranratanaphan S; Taneepanichskul S
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S17-22. PubMed ID: 17726807
[TBL] [Abstract][Full Text] [Related]
14. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
Nappi C; Di Spiezio Sardo A; Greco E; Tommaselli GA; Giordano E; Guida M
Obstet Gynecol; 2005 Jan; 105(1):53-60. PubMed ID: 15625142
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
Ahrendt HJ; Nisand I; Bastianelli C; Gómez MA; Gemzell-Danielsson K; Urdl W; Karskov B; Oeyen L; Bitzer J; Page G; Milsom I
Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
Yonkers KA; Brown C; Pearlstein TB; Foegh M; Sampson-Landers C; Rapkin A
Obstet Gynecol; 2005 Sep; 106(3):492-501. PubMed ID: 16135578
[TBL] [Abstract][Full Text] [Related]
17. Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone.
Oelkers W
Eur J Contracept Reprod Health Care; 2000 Dec; 5 Suppl 3():17-24. PubMed ID: 11246598
[TBL] [Abstract][Full Text] [Related]
18. Is [symbol: see text] Yasmin a "truly different" pill?
Drug Ther Bull; 2002 Aug; 40(8):57-9. PubMed ID: 12216337
[TBL] [Abstract][Full Text] [Related]
19. Serum potassium monitoring for users of ethinyl estradiol/drospirenone taking medications predisposing to hyperkalemia: physician compliance and survey of knowledge and attitudes.
Mona Eng P; Seeger JD; Loughlin J; Oh K; Walker AM
Contraception; 2007 Feb; 75(2):101-7. PubMed ID: 17241838
[TBL] [Abstract][Full Text] [Related]
20. New developments in hormonal therapy for acne.
Tan JK
Skin Therapy Lett; 2007 Sep; 12(7):1-3. PubMed ID: 17940710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
